Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04216719 · ClinicalTrials.gov registry record · NA
Facilitating Opioid Care Connections
A NA study of Opioid Use and Opioid Court Model, sponsored by New York State Psychiatric Institute.
- Active
- Registry status
- NA
- Development phase
- 3,440
- Enrollment target
- 1
- Study location
NCT04216719: Active NA study of Opioid Use and Opioid Court Model, sponsored by New York State Psychiatric Institute.
NCT04216719 is a NA study of Opioid Use and Opioid Court Model that is active but no longer recruiting, run by New York State Psychiatric Institute. The registered enrollment target is 3,440 participants, below the 148,227-participant average among 105 other Opioid Use trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04216719, a NA study of Opioid Use and Opioid Court Model, is active but no longer recruiting, sponsored by New York State Psychiatric Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,440 participants
- Enrollment target
- 1
- Study location
Study Summary
In response to the opioid crisis in New York State (NYS), where the propose project will take place, the Unified Court System (UCS) developed a new treatment court model - the opioid court model (OCM) - designed around 10 practice guidelines to address the flaws of existing drug courts and reduce overdose (OD), opioid use disorder (OUD), and recidivism via rapid screening and linkage to medication for opioid use disorder (MOUD). In 2018, NYS began to expand the OCM across NYS. Yet, given the innovation of the OCM, the exact barriers to implementation in disparate counties with a range of resources - and the strategies to overcome them - are largely unknown. The research team proposes to integrate evidence-based implementation strategies to refine and evaluate the Opioid Court Model Rigorous Implementation Science for Effectiveness (OCM RISE) intervention, an implementation intervention that will allow the OCM, as framed by the 10 practice guidelines, to be scaled up across NYS.
Primary Outcome
Derived from Unified Court Management System (UCMS)
Conditions Studied
Interventions
- BEHAVIORAL OCM-RISE
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,440 participants |
| Start Date | 2020-03-18 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
What the registry record for NCT04216719 still lists
NCT04216719 is an interventional study that assigns participants to a tested intervention. Its 3,440 participants enrollment target places it among the larger protocols in the corpus, below the 148,227-participant average among 105 other Opioid Use trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which OCM-RISE is the first listed.
NCT04216719 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04216719 about?
NCT04216719 is a clinical study titled "Facilitating Opioid Care Connections". In response to the opioid crisis in New York State (NYS), where the propose project will take place, the Unified Court System (UCS) developed a new treatment court model - the opioid court model (OCM) - designed around 10 practice guidelines to address the flaws of existing drug courts and reduce ov...
What is the current status of trial NCT04216719?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,440 participants. The study started on 2020-03-18. Estimated completion is 2026-04-01.
What conditions does trial NCT04216719 study?
This clinical trial studies the following conditions: Opioid Use, Opioid Court Model, Medication to Treat Opioid Use Disorder.
What interventions are being tested in trial NCT04216719?
The interventions under investigation include: OCM-RISE (BEHAVIORAL).
Who is sponsoring clinical trial NCT04216719?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04216719 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04216719's enrollment target sits among peer trials
3,440 6th of 105 higher than 100 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03474029 · 3,400 participants · Phase 2
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
- NCT07142954 · 3,400 participants · Phase 3
Epidemiology and Biomarker Study in Alzheimer's Disease
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI